# Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate

> **NCT00755872** · PHASE1 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 76 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Risedronate
- **DRUG:** Risedronate
- **DRUG:** Risedronate
- **DRUG:** Risedronate

## Key facts

- **NCT ID:** NCT00755872
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2011-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755872, "Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00755872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*